Additional funding to EEC Partners for translational research
The EEC has awarded an additional €50,000 to each of three EEC Partners to carry out further translational research. The EEC are grateful to the External Advisory Board and EEC patient advocates for providing the peer review for the call.
The successful applicants and their projects are:
Pre-clinical validation of Verteporfin to prevent metastatic spread of Ewing sarcoma
Functional biomarkers that identify Ewing’s sarcoma patients at increased risk of relapse
Circulating tumour DNA based analysis of poor prognosis secondary mutations in Ewing sarcoma